People willing to trade treatment efficacy for reduced side effects in cancer therapies

When choosing their preferred treatment, people with chronic lymphocytic leukaemia (CLL) place the highest value on medicines that deliver the longest progression-free survival, but are willing to swap some drug efficacy for a reduced risk of serious...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2B2jOtE
via IFTTT